How I diagnose and treat NPM1-mutated AML
Mutations of the nucleophosmin (NPM1) gene, encoding for a nucleolar multifunctional
protein, occur in approximately one-third of adult acute myeloid leukemia (AML). NPM1 …
protein, occur in approximately one-third of adult acute myeloid leukemia (AML). NPM1 …
[HTML][HTML] Supportive care in patients with cancer during the COVID-19 pandemic
Highlights•Cancer care has been profoundly impacted by the global pandemic of COVID-19,
resulting in unprecedented challenges.•Oncology societies have updated guidelines for the …
resulting in unprecedented challenges.•Oncology societies have updated guidelines for the …
Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub
Abstract Coronavirus disease 2019 (COVID-19) is an illness resulting from severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) that emerged in late 2019. Patients with …
respiratory syndrome coronavirus 2 (SARS-CoV-2) that emerged in late 2019. Patients with …
Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies
P Borah, S Mirgh, SK Sharma, S Bansal, A Dixit… - Blood Cells, Molecules …, 2021 - Elsevier
Background There is scarcity of data on outcome of COVID-19 in patients with hematological
malignancies. Primary objective of study was to analyse the 14-day and 28-day mortality …
malignancies. Primary objective of study was to analyse the 14-day and 28-day mortality …
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)
Patients with acute myeloid leukemia (AML) are at high risk of dying from coronavirus
disease 2019 (COVID-19). The optimal management of AML patients with COVID-19 has not …
disease 2019 (COVID-19). The optimal management of AML patients with COVID-19 has not …
Changes in dietary patterns and clinical health outcomes in different countries during the SARS-CoV-2 pandemic
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has led to an excess in community mortality across the globe …
coronavirus 2 (SARS-CoV-2), has led to an excess in community mortality across the globe …
[PDF][PDF] COVID reference
BS Kamps, C Hoffmann - Munich: Steinhauser Verlang, 2020 - amedeo.com
In not even a year after the discovery of COVID-19, several vaccines have been licensed
and hundreds of millions of people will be vaccinated within months. Soon the number of …
and hundreds of millions of people will be vaccinated within months. Soon the number of …
Diagnostic and therapeutic pitfalls in NPM1-mutated AML: notes from the field
Mutations of Nucleophosmin (NPM1) are the most common genetic abnormalities in adult
acute myeloid leukaemia (AML), accounting for about 30% of cases. NPM1-mutated AML …
acute myeloid leukaemia (AML), accounting for about 30% of cases. NPM1-mutated AML …
Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group
T Palanques-Pastor, JE Megías-Vericat… - Leukemia & …, 2021 - Taylor & Francis
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection produces higher
morbidity and mortality in hematological malignancies, but evidence in acute myeloid …
morbidity and mortality in hematological malignancies, but evidence in acute myeloid …
Nosocomial outbreak of SARS-CoV-2 infection in a haematological unit–High mortality rate in infected patients with haematologic malignancies
MM Biernat, A Zińczuk, P Biernat… - Journal of Clinical …, 2020 - Elsevier
Background Here we report nosocomial outbreak of COVID-19 among patients in a
haematological unit. To our knowledge this is the first report from Central Europe comparing …
haematological unit. To our knowledge this is the first report from Central Europe comparing …